Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis.
Braunstein, G D
The serum concentrations of the myotrophic hormone insulin-like growth factor-I (IGF-I) in 23 patients with amyotrophic lateral sclerosis were not significantly different from those found in the sera of 13 control patients. There was no difference in binding of 125I-IGF-I by serum from patients with amyotrophic lateral sclerosis in comparison with that found in the controls. These results indicate that immunoreactive IGF-I concentrations are normal in patients with amyotrophic lateral sclerosis and that such patients do not have significant antibodies binding their endogenous IGF-I.
ACESSO AO ARTIGOhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1032090
- Bioactive Insulin-Like Growth Factor-I in Obesity
- The Role of Liver-Derived Insulin-Like Growth Factor-I
- Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.
- Increased Intraocular Insulin-like Growth Factor-I Triggers Blood-Retinal Barrier Breakdown*
- Susceptibility to Apoptosis in Insulin-like Growth Factor-I Receptor-deficient Brown Adipocytes